WEDNESDAY, Jan. 15, 2020 -- The cost of essential medications for Multiple Sclerosis have nearly tripled this decade, despite the release of the first generic MS drug, a new study shows. The 2015 release of glatiramer acetate -- the generic version... (Source: - Daily MedNews)

Read full article on


Follow Us on Twitter

Follow Us On Twitter - Image